Drug Profile
FYO 750
Latest Information Update: 28 Mar 2019
Price :
$50
*
At a glance
- Originator Fuji Yakuhin
- Class
- Mechanism of Action Cyclooxygenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Overactive bladder
Most Recent Events
- 28 Mar 2019 No recent reports of development identified for clinical-Phase-Unknown development in Overactive bladder in Japan (Parenteral)
- 19 Feb 2016 Clinical trials in Overactive bladder in Japan (Parenteral)
- 01 Feb 2010 Preclinical trials in Overactive bladder in Japan (Parenteral)